EndoSphere’s endoscopic device treats obesity by working with the body’s natural response to food, targeting the duodenum to amplify satiety and restore its regulatory functions.
Each class is a video session hosted by Tina & Rose, providing deep insight into a specific business topic—whether it’s investor tips or time management.
EndoSphere’s Core Competencies include expertise on treating the Duodenum -- the upper intestinal organ widely recognized for its role as the body’s Metabolic Control Center.
Worldwide obesity has nearly tripled since 1975. Most of the world's population lives in countries where obesity and its co-morbidities are a leading cause of death.
Kenneth Binmoeller, MD, is a published researcher and entrepreneur in gastroenterology and endoscopy, with over 300 research papers, articles, and books. His prior company, Xlumena, developed minimally-invasive endoscopic devices acquired by Boston Scientific in 2015.
EndoSphere creates less-invasive endoscopic devices for obesity treatment by focusing on the duodenum, the body’s metabolic control center, to address limitations of existing therapies.
EndoSphere creates less-invasive endoscopic devices for obesity treatment by focusing on the duodenum, the body’s metabolic control center, to address limitations of existing therapies.
